Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 365

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 365
---
, on February 5, 2025, the Company entered into a securities purchase agreement (the “SPA”) with the investors. The SPA contains customary representations, warranties and agreements of the Company and each investor and customary indemnification rights and obligations of the parties. In connection with this offering, the Company received net proceeds of approximately $ 4.2million, which is net of offering costs and fees of $ 839,004. During the three months ended March 31, 2025, 15,000shares of common stock were purchased upon the closing of the Offering and 91,214shares were issued in connection with the exercise of pre-funded warrants, totaling 106,214shares of its common stock issued of the aggregate amount of 127,551Common Stock shares sold. During the three months ended June 30, 2025, 10,550shares were issued in connection with the exercise of pre-funded warrants. As of September 30, 2025, 10,787pre-funded warrants remain exercisable. The Warrants have an exercise price of $ 39.20per share, are immediately exercisable upon stockholder approval and have a term of exercise equal to five yearsfollowing the initial exercise date. The exercise price and number of shares of Common Stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting the Common Stock and the exercise price. In connection with the Offering, on February 5, 2025, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Alliance Global Partners (“A.G.P.”), as the exclusive placement agent in connection with the Offering (the “Placement Agent”). Pursuant to a side letter between the Placement Agent and JonesTrading Institutional Services LLC (“Jones”), dated February 3, 2025, Jones agreed to be a financial advisor for the Offering. In connection with the services provided by Jones, the Placement Agent and Jones agreed that the Placement Agent will receive an aggregate fee equal to 6% of the gross proceeds received in the Offering and Jones will receive an aggregate fee equal to 3% of the gross proceeds received in the Offering. In addition, the Company agreed to reimburse the Placement Agent for its legal fees and expenses and other out-of-pocket expenses in an amount up to $ 85,000, non-accountable expenses of up to $ 25,000and has agreed to reimburse Jones for all reasonable and documented out-of-pocket fees and expenses, including